8-K
filed August 1, 2024, 7:59 PM ET
CIK 0001805387
M&A
confidence high
sentiment positive
materiality 1.00
AbbVie completes $45/share acquisition of Cerevel; Cerevel becomes wholly owned subsidiary
Cerevel Therapeutics Holdings, Inc.
- Cerevel stockholders received $45.00 per share in cash for each share; total consideration not disclosed.
- All 12 board members resigned; Scott Reents (from Merger Sub) becomes sole director.
- Cerevel shares ceased trading on Nasdaq effective August 1, 2024; deregistration to follow.
- AbbVie reaffirms FY2024 adjusted EPS guidance of $10.71-$10.91, including $0.19 dilutive impact from deal.
- Key assets: emraclidine (schizophrenia, Phase 2 registration-enabling), tavapadon (Parkinson's, Phase 3 met primary endpoint).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Douglas Giordano resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Adam Koppel, M.D., Ph.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Marijn Dekkers, Ph.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Deval Patrick resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Tony Coles, M.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Scott T. Reents was appointed as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Scott T. Reents, the sole director of Merger Sub immediately prior to the Effective Time, became the sole director of Cerevel.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Ruth McKernan, Ph.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Gabrielle Sulzberger resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Suneet Varma resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Ron Renaud resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Norbert Riedel, Ph.D. resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Deborah Baron resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Chris Gordon resigned as Director at Cerevel Therapeutics Holdings, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.